These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 7527760

  • 1. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
    Wiseman LR, Bryson HM.
    Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
    [Abstract] [Full Text] [Related]

  • 2. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
    Dechant KL, Faulds D.
    Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
    [Abstract] [Full Text] [Related]

  • 3. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N, Soll R.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD007836. PubMed ID: 19370695
    [Abstract] [Full Text] [Related]

  • 4. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
    Soll RF, Blanco F.
    Cochrane Database Syst Rev; 2001 Apr 15; (2):CD000144. PubMed ID: 11405951
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Soll RF, Morley CJ.
    Cochrane Database Syst Rev; 2001 Apr 15; (2):CD000510. PubMed ID: 11405966
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.
    Soll RF.
    Cochrane Database Syst Rev; 2000 Apr 15; (2):CD001079. PubMed ID: 10796410
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Calfactant: a review of its use in neonatal respiratory distress syndrome.
    Onrust SV, Dooley M, Goa KL.
    Paediatr Drugs; 1999 Apr 15; 1(3):219-43. PubMed ID: 10937453
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
    Soll RF.
    Cochrane Database Syst Rev; 2000 Apr 15; (2):CD000144. PubMed ID: 10796308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.